CHU clermont-ferrand
Clermont-Ferrand, France
NCT Number: NCT05930769
ImpactRA is an observational retrospective study. The management of the patient is not modified by this study. This study will be carried out based on the already existing data of the gynecological ward of CHU Clermont-Ferrand between 2016 and 2021. During this period of time, 17 patients have undergone laparoscopy, with surgical indication of myomectomy or adenomyomectomy, aided by augmented reality (AR). The investigators compared these 17 patients that underwent surgery with AR with 17 control patients that underwent the same surgery with the same indication but without AR.
Looking for future studies?
Notify Me18 year–84 year
Female
Observational
Clermont-Ferrand, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
(*) An amendment validated by the ethics committee allows inclusion of patients operated during 2016
Minimally invasive gynecological surgery assisted by laparoscope.
Minimally invasive gynecological surgery assisted by laparoscope with the display of additional information through augmented reality.
Time frame: In the intra-operative phase of the study
Assessment of the use of augmented reality during gynecologic laparoscopy defined by the non-increase of the operation time.
Time frame: In the intra-operative phase of the study
Estimating the impact of AR on the amount of bleeding
Time frame: In the post-operative phase of the study
Estimating the impact of AR on the pain measured with the post-operative visual analogue scale (VAS) score. The score on this scale ranges from 0 to 10. The higher the score, the more pain the patient experienced at the time of filling in the scale.
Time frame: In the intra-operative phase of the study
Estimating the impact of AR on the intra-operative complication rate
Time frame: In the intra-operative phase of the study
Estimating the impact of AR on the conversion rate (laparoscopy to laparotomy)
Time frame: In the intra-operative phase of the study
Estimating the impact of AR in the operating room represented by its installation and use during the course of the surgical procedure and estimating the impact of AR on the complexity/difficulty of the procedure recorded in the surgical report
Time frame: From the date of hospital admission to the date of hospital discharge assessed up to 1 week
Estimating the impact of AR on hospitalization duration
Time frame: From the date of hospital discharge to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
Estimating the impact of AR on the time between discharge from hospital and the last post-operative visit (in months)
Time frame: From the date of surgery to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
Estimating the impact of AR on the frequency of post-operative pregnancy
Time frame: From the date of the surgery to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
Estimating the impact of AR on the frequency of recurrence greater than 6 months
Time frame: From the date of the surgery to the date of the latest post-operative visit, assessed up to the last available information for each specific patient (6 years)
Estimating the impact of AR on the post-operative complication rate
University Hospital, Clermont-Ferrand
Other
Retrospective Study on the Evaluation of the Impact of Augmented Reality Usage in Gynecological Laparoscopy on Patients Operated Between 2017 and 2021
Acronym: ImpactRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06067971
Adenomyoma of Uterus, Connective Tissue Diseases
Avignon, France
View Trial DetailsNCT05271981
Connective Tissue Diseases, Fertility Disorders
Paris, France
View Trial DetailsNCT07250178
Abnormal Uterine Bleeding, Connective Tissue Diseases
Diyarbakır, Outside of the US, Turkey (Türkiye)
View Trial DetailsNCT06524934
Connective Tissue Diseases, Endometrial Cancer
Naples, Italy
View Trial Details